1. 1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort. (September 2015) Authors: Martin-babau, J.; Robert, M.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Gourmelon, C.; Brunot, A.; Lefeuvre-plesse, C.; Korenbaum, C.; Petit, T.; Marquis, A.; Bourgeois, H.; Uwer, L.; Som, M.; Desclos, H.; Campone, M.; Campion, L.; Tredan, O.; Patsouris, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN). (September 2015) Authors: Patsouris, A.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Jovenin, N.; Robert, M.; Gourmelon, C.; Korembaum, C.; Petit, T.; Martin-babau, J.; Brunot, A.; Lefeuvre-plesse, C.; Adele, M.; Bourgeois, H.; Som, M.; Uwer, L.; Campone, M.; Campion, L.; Tredan, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2585 Thromboembolic events in patients treated with chemotherapy for testicular germ cell tumors: A retrospective monocentric study of 166 patients. (September 2015) Authors: Boughalem, E.; De Vries, M.; Delva, R.; Abadie-Lacourtoisie, S.; Ceban, T.; Septans, A.L.; Cornuault-Foubert, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗